ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP
Insider CIK 1428992 · ENTL 10% owner · RVNC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENTL ENTELLUS MEDICAL INC | S Sale | 2017-01-31 | 2017-02-02 | 37,998 | $17.00 | $646.0K | 211,159 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | S Sale | 2017-01-31 | 2017-02-02 | 16,521 | $17.00 | $280.9K | 91,808 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | S Sale | 2017-01-31 | 2017-02-02 | 527,022 | $17.00 | $8.96M | 2,928,689 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion deriv | 2015-02-03 | 2015-02-04 | 260,982 | — | $0 | 0 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion deriv | 2015-02-03 | 2015-02-04 | 304,126 | — | $0 | 0 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion deriv | 2015-02-03 | 2015-02-04 | 4,218,108 | — | $0 | 0 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion deriv | 2015-02-03 | 2015-02-04 | 132,228 | — | $0 | 0 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion deriv | 2015-02-03 | 2015-02-04 | 600,259 | — | $0 | 0 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion deriv | 2015-02-03 | 2015-02-04 | 8,325,325 | — | $0 | 0 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | P Buy | 2015-02-03 | 2015-02-04 | 10,027 | $17.00 | $170.5K | 108,329 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion | 2015-02-03 | 2015-02-04 | 3,135,858 | — | $0 | 3,135,858 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | P Buy | 2015-02-03 | 2015-02-04 | 319,853 | $17.00 | $5.44M | 3,455,711 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion | 2015-02-03 | 2015-02-04 | 226,095 | — | $0 | 226,095 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | P Buy | 2015-02-03 | 2015-02-04 | 23,061 | $17.00 | $392.0K | 249,156 | SEC↗ |
| ENTL ENTELLUS MEDICAL INC | C Conversion | 2015-02-03 | 2015-02-04 | 98,302 | — | $0 | 98,302 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other deriv | 2014-04-08 | 2014-04-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 56,485 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 575,384 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 1,801,888 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 404,124 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 596,812 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 369,124 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 41,485 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 129,916 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 29,137 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 43,029 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 26,605 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 18,037 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 12,668 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 18,708 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 11,560 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 18,708 | — | $0 | 105,898 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 87,190 | — | $0 | 87,190 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 26,605 | — | $0 | 270,172 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 43,029 | — | $0 | 243,567 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 11,560 | — | $0 | 117,458 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 369,124 | — | $0 | 3,747,332 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 596,812 | — | $0 | 3,378,208 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 2,781,396 | — | $0 | 2,781,396 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 200,538 | — | $0 | 200,538 | SEC↗ |